Renal artery stenosis

References

Key articles

Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1163-71.Full text  Abstract

Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019 Jan 16;24(2):164-89.Full text  Abstract

Balk EM, Raman G, Adam GP, et al. Renal artery stenosis management strategies: an updated comparative effectiveness review. Comparative effectiveness review no. 179. AHRQ publication no. 16-EHC026-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2016.Full text  Abstract

Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006 Dec 19;145(12):901-12.Full text  Abstract

Pierdomenico SD, Pierdomenico AM, Cuccurullo C, et al. Cardiac events in hypertensive patients with renal artery stenosis treated with renal angioplasty or drug therapy: meta-analysis of randomized trials. Am J Hypertens. 2012 Nov;25(11):1209-14. Abstract

Reference articles

1. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001 Feb 8;344(6):431-42. Abstract

2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006 Mar 21;113(11):e463-654.Full text  Abstract

3. Haller C, Keim M. Current issues in the diagnosis and management of patients with renal artery stenosis: a cardiologic perspective. Prog Cardiovasc Dis. 2003 Nov-Dec;46(3):271-86. Abstract

4. Chonchol M, Linas S. Diagnosis and management of ischemic nephropathy. Clin J Am Soc Nephrol. 2006 Mar;1(2):172-81.Full text  Abstract

5. White CJ, Jaff MR, Haskal ZJ, et al. Indications for renal arteriography at the time of coronary arteriography. Circulation. 2006 Oct 24;114(17):1892-5.Full text  Abstract

6. Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1163-71.Full text  Abstract

7. Kaplan NM. Renovascular hypertension. In: Kaplan NM, ed. Clinical hypertension. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:381-403.

8. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005 Aug 30;112(9):1362-74.Full text  Abstract

9. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002 Sep;36(3):443-51. Abstract

10. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001 Jun;37(6):1184-90. Abstract

11. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004 Apr 29;350(18):1862-71. Abstract

12. Eisenhauer AC, White CJ. Endovascular treatment of noncoronary obstructive vascular disease. In: Libby P, Bonow RO, Mann DL, et al., eds. Braunwald's heart disease. 8th ed. Philadelphia, PA: Elsevier Saunders; 2008:1532-5.

13. Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019 Jan 16;24(2):164-89.Full text  Abstract

14. Mwipatayi BP, Beningfield SJ, White LE, et al. A review of the current treatment of renal artery stenosis. Eur J Vasc Endovasc Surg. 2005 May;29(5):479-88. Abstract

15. Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Apr 2;127(13):1425-43.Full text  Abstract

16. Aboyans V, Ricco JB, Bartelink ME, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018 Mar 1;39(9):763-816.Full text  Abstract

17. Davenport A, Anker SD, Mebazaa A, et al.; Acute Dialysis Quality Initiative (ADQI) Consensus Group. ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010 Jul;25(7):2077-89.Full text  Abstract

18. Zucchelli PC. Hypertension and atherosclerotic renal artery stenosis: diagnostic approach. J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S184-6.Full text  Abstract

19. Utsunomiya D, Miyazaki M, Nomitsu Y, et al. Clinical role of non-contrast magnetic resonance angiography for evaluation of renal artery stenosis. Circ J. 2008 Oct;72(10):1627-30.Full text  Abstract

20. Khoo MM, Deeab D, Gedroyc WM, et al. Renal artery stenosis: comparative assessment by unenhanced renal artery MRA versus contrast-enhanced MRA. Eur Radiol. 2011 Jul;21(7):1470-6. Abstract

21. Angeretti MG, Lumia D, Canì A, et al. Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography. Acta Radiol. 2013 Sep;54(7):749-56. Abstract

22. Caridi JG, Stavropoulos SW, Hawkins IF Jr. CO2 digital subtraction angiography for renal artery angioplasty in high-risk patients. AJR Am J Roentgenol. 1999 Dec;173(6):1551-6.Full text  Abstract

23. Lorch H, Steinhoff J, Fricke L, et al. CO2 angiography of transplanted kidneys [in German]. Rontgenpraxis. 2003;55(1):26-32. Abstract

24. Liss P, Eklöf H, Hellberg O, et al. Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study. J Vasc Interv Radiol. 2005 Jan;16(1):57-65. Abstract

25. Gerhard-Herman M, Gardin JM, Jaff M, et al. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006 Nov;11(3):183-200.Full text  Abstract

26. Olbricht CJ, Paul K, Prokop M, et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 1995 Oct;48(4):1332-7. Abstract

27. Radermacher J. Resistive index: an ideal test for renovascular disease or ischemic nephropathy? Nat Clin Pract Nephrol. 2006 May;2(5):232-3. Abstract

28. Mangiacapra F, Trana C, Sarno G, et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension. Circ Cardiovasc Interv. 2010 Dec;3(6):537-42.Full text  Abstract

29. Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009 Jun 23;53(25):2363-71.Full text  Abstract

30. De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006 Nov 7;48(9):1851-5.Full text  Abstract

31. American College of Radiology. ACR appropriateness criteria: renovascular hypertension. 2017 [internet publication].Full text

32. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-53. Abstract

33. Gerstein HC, Miller ME, Byington RP, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59.Full text  Abstract

34. Patel A, MacMahon S, Chalmers J, et al; The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560-72.Full text  Abstract

35. Miyamori I, Yasuhara S, Takeda Y, et al. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension. 1986 May;8(5):415-21. Abstract

36. Reams GP, Singh A, Logan KW, et al. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition. J Clin Hypertens. 1987 Jun;3(2):153-63. Abstract

37. Plouin PF, Chatellier G, Darné B, et al; Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension. 1998 Mar;31(3):823-9.Full text  Abstract

38. Van Jaarsveld BC, Krijnen P, Pieterman H, et al; Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med. 2000 Apr 6;342(14):1007-14.Full text  Abstract

39. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens. 1998 May;12(5):329-35. Abstract

40. Krijnen P, van Jaarsveld BC, Deinum J, et al. Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention? J Hum Hypertens. 2004 Feb;18(2):91-6. Abstract

41. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014 Jan 2;370(1):13-22. Abstract

42. Cheung CM, Patel A, Shaheen N, et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107(2):c35-42. Abstract

43. Hanzel G, Balon H, Wong O, et al. Prospective evaluation of aggressive medical therapy for atherosclerotic renal artery stenosis, with renal artery stenting reserved for previously injured heart, brain, or kidney. Am J Cardiol. 2005 Nov 1;96(9):1322-7. Abstract

44. Uder M, Humke U. Endovascular therapy of renal artery stenosis: where do we stand today? Cardiovasc Intervent Radiol. 2005 Mar-Apr;28(2):139-47. Abstract

45. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20.Full text  Abstract

46. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):e13-115.Full text  Abstract

47. Balk EM, Raman G, Adam GP, et al. Renal artery stenosis management strategies: an updated comparative effectiveness review. Comparative effectiveness review no. 179. AHRQ publication no. 16-EHC026-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2016.Full text  Abstract

48. Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006 Dec 19;145(12):901-12.Full text  Abstract

49. Pierdomenico SD, Pierdomenico AM, Cuccurullo C, et al. Cardiac events in hypertensive patients with renal artery stenosis treated with renal angioplasty or drug therapy: meta-analysis of randomized trials. Am J Hypertens. 2012 Nov;25(11):1209-14. Abstract

50. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984 Aug;11(3):383-92. Abstract

51. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992 May;2(11):1608-16. Abstract

52. Franklin SS, Smith RD. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med. 1985 Sep 27;79(3C):14-23. Abstract

53. Tillman DM, Malatino LS, Cumming AM, et al. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function. J Hypertens Suppl. 1984 Dec;2(2):S93-100. Abstract

54. Alonso A, Lau J, Jaber BL, et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis. 2004 Jan;43(1):1-9. Abstract

55. Pannu N, Wiebe N, Tonelli M, et al. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006 Jun 21;295(23):2765-79.Full text  Abstract

56. Pizzolo F, Mansueto G, Minniti S, et al. Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg. 2004 Jan;39(1):140-7. Abstract

57. Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005 Sep 6;46(5):776-83. Abstract

58. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997 Nov 15;30(6):1445-50. Abstract

59. Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology. 2003 Mar;226(3):821-6. Abstract

60. Dorros G, Jaff M, Mathiak L, et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year followup of 1,058 successful patients. Catheter Cardiovasc Interv. 2002 Feb;55(2):182-8. Abstract

61. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999 Jan 23;353(9149):282-6. Abstract

62. Gonçalves JA, Amorim JE, Soares Neto MM, et al. Clinical efficacy of percutaneous renal revascularization with stent placement in atherosclerotic renovascular disease. Arq Bras Cardiol. 2007 Jan;88(1):85-90.Full text  Abstract

63. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006;113:e463-e654.Full text  Abstract

Use of this content is subject to our disclaimer